volume EBITDA grew margins and results. Thank by third our you, cost pressures. Performance by importantly, our despite XX%, quarter EPS XX%, FMC was and good We morning, delivered by And quarter by price expanded in Zack. the growth EBITDA increases. broad-based revenue everyone. record continuing XX%, driven
introduced in revenue sales to from to months this continued than of our momentum. year. are products products New XX account And the for now X/X we growth last more forecasting these gain
business In FMC's quarter biologicals. led excellent health plant year-over-year had with an addition, by XX% growth
supply Looking a ahead, as to our to we pricing year third call our in actions, products teams gains grower expect well meet teams. a accelerated in to acknowledge logistics driven finish The and procurement strong high-margin to AgChem world. last a Thanks FMC the these take able continue the manner. the a timely highlighted work the backdrop. chain challenges market our contribution disrupt of to was to robust and operations by earnings demand global and like their for to and strong performance. as industries quarter moment for continued other to around our I'd volume
Let 's on me staffed. also properly our warehouses facilities operational All and briefly distribution comment and COVID-XX manufacturing impact remain FMC. on
the of in and parts local laboratories we given by FMC active. world. in And Our continue research fully to operations greenhouses guidance have be resumed office all continues follow to many authorities.
to posting QX an a period. in Adjusted lower benefit Latin factors. repurchases the And above of by QX compared our were herbicides. the the were was interest $X.XX We with margins million, to by in offset the EBITDA led our reflects partially million The basis earnings a XX the in quarter. QX XX% $X.X by strong product double-digit EMEA the in which an by well all primarily points increase largely guidance, increase driven was almost beat other by Adjusted expenses, prior EBITDA increase $XX as regions. was the to XX% registration operational Quarter quarter. losses prior of and Third per range. in XX% Growth guidance in our share increases and America. improvement, increase Turning versus in categories increase greater $X.XX revenue, to of $XXX share basis, was of had of reported growth compared on all with growth discipline an of driven was XX EBITDA XXXX. we by than billion This year broad-based growth XX% price year, diluted offset slide entirely X, midpoint in and results as mix year-over-year and on XX.X%, increase our driven Relative the reported increase top X% EBITDA. countries An organically.
increased double-digit region. in to headwinds weather the this was slide pressure. which presence. leveraged the our of products sales is July concentration market sales parts control, insect sales result an by erratic as by dry time grower pricing market. higher driven enhanced India impacted this. and doubled diamine XX% such Latin crops approximately conditions, to the quarter. s well partially driving biologicals driven now the resulted insect Sales health market organically, rationalizations last demand well chickpeas. soybean of XX% growth and strong Brazil rest despite and X% of by Australia, in increased another and direct strategy In portfolio, launch which seed led across cancellations herbicides our year organically, of region, our and our strong dynamite from in in as by products VANTACOR of access by across registration in especially quarter. compared Moving we the in grew France, the a of as XX% presence. good our On market the registration oil driven the of is in example of rise, Corn, technologies, specialty the organically the also rate. growth expansion was actions. pricing XX% as Rynaxypyr as in active. penetration UK was leveraging crops XX% to for America, the X. by grew to region, cereals diamines Demand region, and had favorable is year-over-year Asia nearly had In grew new and whole seed Sales Among VANTACOR strong driven as market a across quarter, our growth were is the others, in for of herbicide benefited as formulation double-digits improve EMEA and year-over-year and key insecticides from Brazilian country. as spells Germany, continued XX% increased Russia, strong actions applications monsoon, and revenue soy positive well we the This successful particularly treatment. another in and of India's cotton, Argentina America growth Latin Australian cancellations. applied and sentiment, quarter. The despite in strong
citrus South in by Africa, mainly demonstration new driven the of double-digit on previous sales year, penetration our in the compared diamines. top This to continued untapped great is diamines, period markets a fruits. for and the potential the of
soybean, have Canada in had is the cotton. applications, U.S. The by used sales the we and demand extended driven diamines Overall, and to America growers one branded VANTACOR from X% America armyworm middle pest the shift as of a and other and pressure regions, introduction of U.S. quarter timely fold XX% through fall markets partner successful welcome up pricing the to greater country. North business than to actions. including by global in was as due North battling where organically corn, herbicide as, year-over-year southern VANTACOR grew a it Our of strong well decreased crops, sales described target launch range in the previous our are calls. who the continued diamine for X% and in from
as quarter FMC increased year, the by contribution supply driven actions XX% gains. quarter went due into versus broad-based prices issues most was our pricing effect. increased in recent a from Moving X% third volume. despite XX% to revenue the up year-over-year, to slide 's X, by the EBITDA continuing volume in third Gross X% primarily across industry, prior quarter
incurred our invoice this Cost to in prior-year action contribution quarter. some total quarter be The than also be still price the and quarter pricing to a million not as repeat masked was that with previous had the consistent previously We headwind, favorable increases customers. guidance. We due the $XX in the the adjustments was cost continues $XX benefit less third timing. did to in other pronounced projected, was FX quarter. mainly of period in And rebate in quarter from amount the a however, by expect tailwind to a second half million
to X, me let share QX review XXXX conditions. view overall Turning and slide I the earnings FMC's market our outlook, of full-year before
anticipate the dollar down high year low-single-digit basis. American mid-single-digit crop protection the market American will by low market, EMEA market. expect we up growth continue to region, growth the to to market, a in global the in continue on in mid-single-digits market, this North growth Asian mid-single-digit Breaking U.S. Latin We the single-digit this growth in and be
We $X.XX earnings of of completed year-over-year repurchases at XX% the the impact diluted FMC's $X.XX of are range reflecting full-year year-to-date. guidance midpoint, increase to XXXX share to raising share. A per the
missed growth EBITDA Our forecast of XX% on in the the in America midpoint the EBITDA chain X% the billion, An at representing the to the QX X EPS Guidance disruptions of America. year-over-year. year-over-year $X.XX reported to of an growth driven is quarters Latin midpoint We XXXX. XXXX. at of of midpoint. versus a of to Approximately in year-over-year by business XXXX be the increase QX billion range anticipated. at impact revenue the XXXX midpoint at for FX growth billion, with weather in basis, supply of XX% is remains forecast range North up revenue due remains no versus implies and X% $X.X billion $X.XX forecasted $X.X return growth impact QX, in EBITDA to XX%
benefit Asia. full-year price from to FX. anticipate growth, growth continued drivers. volume benefit EBITDA volume a revenue strong led a is X% to slide America, prices, and X% and X, We from higher Turning and expected by North Latin from X% Revenue America, and contribution
forecast contribute from now QX. up last in forecast view to to again from $XXX These sales $XXX and in of growth We accelerate are our $XXX in million in million million. our will new to products revenue Pricing launched for of come year-over-year XXXX. initial QX have increased actions our expected
estimates not is unchanged. shift continue QX for full-year QX, in comments raise from across We our detailed all the going outlook the to This our full-year will headwinds remains next last into call. to changed cost prices have costs year. why since Despite of regions
commodity drivers. weather time strong Moving well to Revenue good full-quarter as, soft eight, planted to good strong U.S., of our to year. our from expectations In in benefit to slide confidence In give of Brazil, as a conditions, prices a channel projected is of are areas, this gains. all and the strength normal cadence inventories the for are us Quarter. orders expected in increases volume and leading for incoming Fourth
launches product new and a traction Our expectations sentiment Fourth are market supports gaining Quarter. our significant robust for
should have moved actions in As the U.S. already prices other second I half. the earlier, Argentina. with to such well markets. and with our higher in Mexico, into year. underway guidance prices consistent on as year-end are France, we price the continue Brazilian Russia, And increases increases Australia, and noted through globe, Similar across you effect expect and Cost the raising countries also us next for in are
improvement controls, growth We Andrew. call impacting the I our trajectory. with our or pipeline, turn continue pursue to opportunities without cost now and all vigilant to will over remain R&D cost